Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
FOMEPIZOLE (UNII: 83LCM6L2BY) (FOMEPIZOLE - UNII:83LCM6L2BY)
American Regent, Inc.
INTRAVENOUS
PRESCRIPTION DRUG
Fomepizole injection is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis (see DOSAGE AND ADMINISTRATION). Fomepizole injection should not be administered to patients with a documented serious hypersensitivity reaction to fomepizole injection or other pyrazoles.
Fomepizole is supplied as a sterile, preservative-free solution for intravenous use as: Supplied in single vial cartons. Each vial contains 1.5 mL (1 g/mL) of fomepizole. NDC 0517-0710-88 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Manufactured by: American Regent, Inc. Shirley, NY 11967 RQ1088-B Revised: November 2020 Novaplus is a registered trademark of Vizient, Inc.
Abbreviated New Drug Application
FOMEPIZOLE- FOMEPIZOLE INJECTION, SOLUTION AMERICAN REGENT, INC. ---------- FOMEPIZOLE INJECTION STERILE RX ONLY _CAUTION: MUST BE DILUTED PRIOR TO USE. DO NOT USE POLYCARBONATE SYRINGES OR POLYCARBONATE-CONTAINING_ _NEEDLES (INCLUDING POLYCARBONATE FILTER NEEDLES) WITH FOMEPIZOLE INJECTION. _ DESCRIPTION Fomepizole injection is a competitive inhibitor of alcohol dehydrogenase. The chemical name of fomepizole is 4-methylpyrazole. It has the molecular formula C H N and a molecular weight of 82.1. The structural formula is: It is a clear to yellow liquid at room temperature. Its melting point is 25° C (77° F) and it may present in a solid form at room temperature. Fomepizole is soluble in water and very soluble in ethanol, diethyl ether, and chloroform. Each vial contains 1.5 mL (1 g/mL) of fomepizole. CLINICAL PHARMACOLOGY MECHANISM OF ACTION: Fomepizole is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Ethylene glycol, the main component of most antifreezes and coolants, is metabolized to glycoaldehyde, which undergoes subsequent sequential oxidations to yield glycolate, glyoxylate, and oxalate. Glycolate and oxalate are the metabolic by-products primarily responsible for the metabolic acidosis and renal damage seen in ethylene glycol toxicosis. The lethal dose of ethylene glycol in humans is approximately 1.4 mL/kg. Methanol, the main component of windshield wiper fluid, is slowly metabolized via alcohol dehydrogenase to formaldehyde with subsequent oxidation via formaldehyde dehydrogenase to yield formic acid. Formic acid is primarily responsible for the metabolic acidosis and visual disturbances (e.g., decreased visual acuity and potential blindness) associated with methanol poisoning. A lethal dose of methanol in humans is approximately 1-2 mL/kg. Fomepizole has been shown in vitro to block alcohol de Lugege kogu dokumenti